• Johanna M. Hauer
  • Mo Banki
  • Elie M. Ferneini


This chapter explores three different, yet interrelated, topics essential for the practice of oral and maxillofacial surgery. It addresses the current evidence-based treatment recommendations for osteomyelitis, medication-related osteonecrosis of the jaw (MRONJ), and osteoradionecrosis (ORN). Additionally, this chapter addresses the etiology, diagnosis, and staging of MRONJ/BRONJ and ORN, as well as the subcategories of osteomyelitis of the jaws, including acute suppurative osteomyelitis, chronic suppurative osteomyelitis, chronic sclerosing osteomyelitis, and juvenile mandibular chronic osteomyelitis (JMCO).


  1. Assael LA. Bisphonsphonates and oral health: primer and an update for the practicing surgeon. Oral Maxillofac Surg Clin North Am. 2011;23:443–53.PubMedCrossRefGoogle Scholar
  2. Bagheri S, Girn J, Jo C. Clinical review of oral and maxillofacial surgery. Mosby: Elsevier; 2008. p. 85–8.Google Scholar
  3. Beuselinck B, Wolter P, Karadimou A, et al. Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases. Br J Cancer. 2012;107:1665.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Bevin CR, Inwards CY, Keller EE. Surgical management of primary chronic osteomyelitis: a long-term retrospective analysis. J Oral Maxillofac Surg. 2008;66:2073–85.PubMedCrossRefGoogle Scholar
  5. Bruins HH, Koole R, Jolly DE, et al. Pretherapy dental decisions in patients with head and neck cancer. A proposed model for dental decision support. Oral Surg Oral Med Pathol Oral Radiol Endod. 1998;86:256–67.CrossRefGoogle Scholar
  6. Carlson ER, Basile JD. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67(5, Suppl. 1):85–95.PubMedCrossRefGoogle Scholar
  7. Ceponis P, Keilman C, Guerry C, Freiberger JJ. Hyperbaric oxygen therapy and osteonecrosis. Oral Dis. 2017;23(2):141–51.PubMedCrossRefGoogle Scholar
  8. Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol. 2006;35:236–43.PubMedCrossRefGoogle Scholar
  9. Delanian S, Depondt J, Lefaix JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck. 2005;27:114–23.PubMedCrossRefGoogle Scholar
  10. Dimopoulos MA, Kastritis E, Bamia C, et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol. 2009;20(1):117–20.PubMedCrossRefGoogle Scholar
  11. Dodson TB. The frequency of medication-related osteonecrosis of the jaw and its associated risk factors. Oral Maxillofac Surg Clin North Am. 2015;27:509–16.PubMedCrossRefGoogle Scholar
  12. Dym H, Zeidan J. Microbiology of acute and chronic osteomyelitis and antibiotic treatment. Dent Clin N Am. 2017;61:271–82.PubMedCrossRefGoogle Scholar
  13. Ecury-Goossen M, Huysman A, Verhallen-Dantuma CTM, et al. Sequential intravenous-oral antibiotic therapy for neonatal osteomyelitis. Pediatr Infect Dis J. 2009;28(1):72–3.CrossRefGoogle Scholar
  14. Fliefel R, Troltzsch M, Kuhnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw [BRONJ] with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 2015;44:568–85.PubMedCrossRefGoogle Scholar
  15. Goodday RH. Preventive strategies of patients at risk of medication-related osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am. 2015;27:527–36.PubMedCrossRefGoogle Scholar
  16. He Y, Liu Z, Tian T, et al. Retrospective analysis of osteoradionecrosis of the mandible: proposing a novel clinical classification and staging system. Int J Oral Maxillofac Surg. 2015;44:1547–57.PubMedCrossRefGoogle Scholar
  17. Helm C, et al. Management of acute osteomyelitis: a ten-year experience. Infect Dis Rep. 2016;8(3):63–7.CrossRefGoogle Scholar
  18. Hinson AM, Smith CW, Siegel ER, et al. Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary. Int J Dent. 2014;2014:452737.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Hjorting-Hansen E. Decortication in treatment of osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol. 1970;29(5):641–55.PubMedCrossRefGoogle Scholar
  20. Holzinger D, Seemann R, Klug C, et al. Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws [BRONJs]. Oral Oncol. 2013;49:66–70.PubMedCrossRefGoogle Scholar
  21. Hudson JW. Osteomyelitis of the jaws: a 50-year perspective. J Oral Maxillofac Surg. 1993;51(12):1294–301.PubMedCrossRefGoogle Scholar
  22. Jacobsson S. Discussion: isolation of Actinomyces species and Eikenella Corrodens from patients with chronic diffuse sclerosing osteomyelitis. J Oral Maxillofac Surg. 1994;52:33–4.CrossRefGoogle Scholar
  23. Kim KM, et al. Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int. 2014;25:1625–32.PubMedCrossRefGoogle Scholar
  24. Kim HY, et al. Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis. J Oral Maxillofac Surg. 2017;75:1404–13.PubMedCrossRefGoogle Scholar
  25. Kluth E, Jain PR, Stuchell RN, et al. A study of factors contributing to the development of osteora- dionecrosis of the jaws. J Prosthet Dent. 1988;59(2):194–201.PubMedCrossRefGoogle Scholar
  26. Kojima Y, Yanamoto S, Umeda M, et al. Relationship between dental status and development of osteoradionecrosis of the jaw: a multi center retrospective study. J Oral Maxillofac Surg. 2007;124(2):139–45.Google Scholar
  27. Koorbusch GF, Deatherage JR. How can we diagnose and treat osteomyelitis of the jaws as early as possible? Oral Maxillofac Surg Clin North Am. 2011;23:557–67.PubMedCrossRefGoogle Scholar
  28. Koorbusch GF, Fotos P, Terhark-Goll K. Retrospective assessment of osteomyelitis: etiology, demo- graphics, risk factors, and management in 35 cases. Oral Surg Oral Med Oral Pathol. 1992;74(2):149–54.PubMedCrossRefGoogle Scholar
  29. Krakowiak PA. Alveolar osteitis and osteomyelitis of the jaws. Oral Maxillofac Surg Clin North Am. 2011;23:401–13.PubMedCrossRefGoogle Scholar
  30. Kumar SK, Gorur A, Schaudinn C, et al. The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy. Curr Osteoporos Rep. 2010;8(1):40–8.PubMedCrossRefGoogle Scholar
  31. Kyrgidis A, Toulis KA. Denosumab-related osteonecrosis of the jaws. Osteoporos Int. 2011;22(1):369–70.PubMedCrossRefGoogle Scholar
  32. Kyrgidis A, Vahtsevanos K, Koloutsos G, et al. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol. 2008;26:4634.PubMedCrossRefGoogle Scholar
  33. Kyrgidis A, Koloutsos G, Vahtsevanos K. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws. Head Neck. 2009;31(8):1112–3. [author reply 1113–4]PubMedCrossRefGoogle Scholar
  34. Landesberg R, Woo V, Cremers S, et al. Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci. 2011;1218:62–79.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Lee IJ, Woong SK, Chang GL, et al. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2009;75(4):1084–91.PubMedCrossRefGoogle Scholar
  36. Lo JC, O’Ryan FS, Gordon NP, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010;68:243.PubMedCrossRefGoogle Scholar
  37. Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg. 2008;46(8):653–60.PubMedCrossRefGoogle Scholar
  38. Marx R. Osteoradionecrosis: a new concept in its pathophysiology. J Oral Maxillofac Surg. 1983;41:283–8.PubMedCrossRefGoogle Scholar
  39. Marx RE. Pamidronate [Aredia] and Zolendronate [Zometa] induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115–8.PubMedCrossRefGoogle Scholar
  40. Marx RE, Carlson ER, Smith BR, Toraya N. Isolation of actinomyces species and Eikenella corrodens from patients with chronic diffuse sclerosing osteomyelitis. J Oral Maxillofac Surg. 1994;52:26–33.PubMedCrossRefGoogle Scholar
  41. Moon DH, Moon SH, et al. Incidence of, and risk factors for, mandibular osteoradionecrosis in patient with oral cavity and oropharynx cancers. Oral Oncol. 2017;72:98–103.PubMedCrossRefGoogle Scholar
  42. Neto T, et al. Resection and microvascular reconstruction of bisphosphonate-related osteonecrosis of the jaw: The role of microvascular reconstruction. Head Neck. 2016;38(8):1278–85.PubMedCrossRefGoogle Scholar
  43. Neville BW. Oral and maxillofacial pathology. St. Louis, MO: Saunders; 2009. p. 141–50.Google Scholar
  44. O’Dell K, Sinha U. Osteoradionecrosis. Oral Maxillofac Surg Clin North Am. 2011;23:455–64.PubMedCrossRefGoogle Scholar
  45. Owosho AA, Kadempour A, Yom SK, et al. Radiographic osteoradionecrosis of the jaw with intact mucosa: proposal of clinical guideline for early identification of this condition. Oral Oncol. 2015;15(12):e93–6.CrossRefGoogle Scholar
  46. Qi W, et al. Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. Int J Clin Oncol. 2014;19:403–10.PubMedCrossRefGoogle Scholar
  47. Renapurkar S, Pasternack M, Nielsen PG, Kaban LB. Juvenile mandibular chronic osteomyelitis: role of surgical debridement and antibiotics. J Oral Maxillofac Surg. 2015;73(9):e41–2.CrossRefGoogle Scholar
  48. Ruggerio SL. Diagnosis and staging of medication-related osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am. 2015;27:479–87.CrossRefGoogle Scholar
  49. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62(5):527–34.PubMedCrossRefGoogle Scholar
  50. Ruggiero SL, Dodson TB, Fantasia J, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg. 2014;72(10):1938–56.PubMedCrossRefGoogle Scholar
  51. Sammut S, et al. Juvenile chronic mandibular osteomyelitis: a case series defining the clinico-pathological features of this rare condition. Br J Oral Maxillofac Surg. 2014;52(8):e43–74.Google Scholar
  52. Santosh ABR, Ogle OE, Williams D, Woodbine EF. Epidemiology of Oral and Maxillofacial Infections. Oral Maxillofac Surg Clin North Am. 2017;61:217–33.Google Scholar
  53. Schneider LC, Mesa ML. Differences between florid osseous dysplasia and chronic diffuse sclerosing osteomyelitis. Oral Surg Oral Med Pathol. 1990;70:308–12.CrossRefGoogle Scholar
  54. Schuknecht B, Valavanis A. Osteomyelitis of the mandible. Neuroimaging Clin N Am. 2003;13:605–18.PubMedCrossRefGoogle Scholar
  55. Schulze D, Blessman M, Pohlenz P, Wagner KW, Heiland M. Diagnostic criteria for the detection of mandibular osteomyelitis using cone-beam computed tomography. Dentomaxillofac Radiol. 2006;35:232–5.PubMedCrossRefGoogle Scholar
  56. Schwartz HC, Kagan AR. Osteoradionecrosis of the mandible. Am J Clin Oncol. 2002;25(2):168–71.PubMedCrossRefGoogle Scholar
  57. Scoletta M, et al. Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol. J Oral Maxillofac Surg. 2013;71:994–9.PubMedCrossRefGoogle Scholar
  58. Shintani T, et al. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral ind intravenous bisphosphonates. Int J Oral Maxillofac Surg. 2015;44:840–4.PubMedCrossRefGoogle Scholar
  59. Spanou A, et al. Management of bisphosphonate-related osteonecrosis of the jaw: a literature review. Oral Dis. 2015;21:927–36.PubMedCrossRefGoogle Scholar
  60. Tsao C, et al. Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg. 2013;71:1360–6.PubMedCrossRefGoogle Scholar
  61. Vahtsevanos K, Kyrgidis A, Verrou E, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol. 2009;27:5356–62.PubMedCrossRefGoogle Scholar
  62. Van Merkesteyn JPR, et al. Hyperbaric oxygen treatment of chronic osteomyelitis of the jaws. Int J Oral Surg. 1984;13:386–95.PubMedCrossRefGoogle Scholar
  63. Vandone AM, Donadio M, Mozzati M, et al. Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol. 2012;23:193.PubMedCrossRefGoogle Scholar
  64. Vercruysse H Jr, Backer TD, Mommaerts MY. Outcomes of osseous free flap reconstruction in stage III bisphosphonate-related osteonecrosis of the jaw: systematic review and a new case series. J Craniomaxillofac Surg. 2014;42:377–86.PubMedCrossRefGoogle Scholar
  65. Williams WB. Management of medication-related osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am. 2015;27:517–25.PubMedCrossRefGoogle Scholar
  66. Wong JK, Wood RE, McLean M. Conservative management of osteoradionecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:16.PubMedCrossRefGoogle Scholar
  67. Yamazaki T, Yamori M, Ishizaki T, et al. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg. 2012;41:1397.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Johanna M. Hauer
    • 1
  • Mo Banki
    • 2
    • 3
    • 4
  • Elie M. Ferneini
    • 5
    • 6
  1. 1.Department of Oral and Maxillofacial SurgeryUniversity of Connecticut School of Dental MedicineFarmingtonUSA
  2. 2.Artistic Contours and MSL SurgeryWarwickUSA
  3. 3.Department of Surgery, Clinical FacultyWarren Alpert Medical School of Brown UniversityProvidenceUSA
  4. 4.Division of Oral and Maxillofacial Surgery, Clinical FacultyUniversity of ConnecticutFarmingtonUSA
  5. 5.Beau Visage Med Spa, Greater Waterbury OMSCheshireUSA
  6. 6.Division of Oral and Maxillofacial SurgeryUniversity of ConnecticutFarmingtonUSA

Personalised recommendations